Could AI predict outcomes and side-effects of radiotherapy in men with #prostatecancer? Prostate Cancer UK funded Prof. Bill Nailon and Prof. Duncan McLaren @edinburgh-uni.bsky.social detail how they'll answer this question in BMJ Open. Grab a ☕ and read: bmjopen.bmj.com/content/16/2...

The February edition of Research News is here! Discover more about: 🔬 An exciting research project. 💸 Our new funding committee chairs. 💙 Our updated Research Impact webpages. 🏆 Researcher achievements. 💰 Funding opportunities. 📖 Read it here: buff.ly/azyVGlK

💻 Prostate Cancer UK Online Learning Free courses, webinars & resources to build your knowledge and earn self-accredited CPD. Flexible, practical learning for busy health professionals. ➡️ buff.ly/gm2hkMG #ProstateCancer #CPD

📢 We’re supporting @acmedsci.bsky.social to provide up to £40K over 2 years to Clinical Lecturers looking to develop and strengthen their research careers. Funding deadline is 26 February 2026. Visit AMS website for more info 👉 acmedsci.ac.uk/starter-grants #CareerDevelopment #ResearchFunding

Can AI learn to detect aggressive #ProstateCancer on MRI with limited expert input? A team, including Prostate Cancer UK–funded Profs. Hashim Ahmed & Mark Emberton, publish findings in @europeanradiology.bsky.social powered by data from our funded research. Grab a ☕ & read: doi.org/10.1007/s003...

📢 Do you know any rising stars⭐ in prostate cancer research? 🔬 Our Career Acceleration Fellowships offer up to £350k to help early career researchers pursue their own research goals and become future leaders in the field. Share with your team today!

Professor Jonathan Coulter @qubelfastofficial.bsky.social leads a research team developing innovative cancer therapeutics. Since 2021, we’ve supported his team in creating an implant that releases gold nanoparticles that sensitise #ProstateCancer to radiotherapy. 📙 Read more: buff.ly/vteN8gz

💻 Join our free online Specialists Conference on 25–26 March for the latest updates in prostate cancer care. Busy on the day? No worries — we’ll send you the recordings. ➡️ More details here: bit.ly/3EaVj3i #prostatecancer #professionaldevelopment #secondarycare

[1/10] 🧵 How does IGF-1 help cancer cells evade the immune system? Let's unpack the results observed in a recently published article in Scientific Reports by a team including Prostate Cancer UK funded Professor Valentine Macaulay and Professor Ian Mills. bsky.app/profile/did:...

Could molecular profiling of circulating tumour cells (CTCs) improve clinical management of #ProstateCancer? Progress on this topic is reviewed by a team including Prostate Cancer UK funded Professor Yong-Jie Lu @qmbci.bsky.social in @natrevurol.nature.com. Grab a ☕ and read: bit.ly/46ti2CJ

📢 Seize the opportunity to boost your future research career as a Clinical Lecturer! Thanks to @prostatecanceruk.bsky.social partnership with @acmedsci.bsky.social, you can apply for a Starter Grant by 26 February 2026. Learn more 👉 acmedsci.ac.uk/starter-grants #researchfunding #prostatecancer

⏰ 12 days to go: CRSG proposal deadline 💡 Got a new trial idea to improve outcomes for men with prostate cancer? Get early guidance and feedback from the CRSG. 🗓 Deadline: 4pm, Fri 13 Feb

Could GALNT7 be a promising therapeutic target for #ProstateCancer? A team led by Dr Jennifer Munkley @newcastleuni.bsky.social explores the enzyme's role & emerging strategies to inhibit its activity, writing in Expert Opinion on Therapeutic Targets. Grab a ☕ & read: doi.org/10.1080/1472...

📢 Are you a Clinical Lecturer looking to develop and strengthen your research career? The @acmedsci.bsky.social Starter Grants funding call is now OPEN. Deadline: 26 February 2026. More details 👉 acmedsci.ac.uk/starter-grants #CareerDevelopment #ResearchFunding

The January edition of Research News is here! Find out about: 🎯 How we measure the success of our funded research 🥼 UK Prostate Cancer Clinical Research Strategy Group 🧪 Research funding opportunities 📖 External workshops Read here: buff.ly/l43rtlW

Coming soon! 📢 Applications for our Career Acceleration Fellowships open in March. We’re offering up to £350K over 3-4 years to support early career prostate cancer researchers to advance their career and build collaborations. 🚨Find out more here: buff.ly/E2yRcy8

Huge congratulations to @mitosrus.bsky.social and the team @cruk-si.bsky.social for this well deserved recognition 👏

💊 NHS England expands access to abiraterone for high-risk localised & locally advanced prostate cancer ⏰ Clinicians: REVIEW diagnoses from the last 12 weeks to ensure eligible patients start treatment before they “time out” of eligibility. More info ➡️ buff.ly/qSao7sk

Could androgen-regulated amyloid precursor protein processing drive #ProstateCancer development? A team including Prostate Cancer UK Career Acceleration Fellow Dr Rachel Barker @bristoluni.bsky.social share a systematic review in Curr. Issues Mol. Biol. Grab a ☕ and read: doi.org/10.3390/cimb...

🗓️ Just 3 months to go until From Ideas to Innovation! 🚄 Book your travel now - tickets are cheaper & more options. 💸 Travel may be covered by your Prostate Cancer UK grant. 🎟️ Travel bursaries available - first come, first served. More info 👇 prostatecanceruk.org/research/for...

⏰ Time's ticking ⏰ Enhance prostate cancer care and support with our dynamic Improvement Programmes team. 🚀 Final call to be a part of our Clinical Champions Cohort 5 🌟 Apply now:

⏰ 1 month to go: CRSG proposal deadline 💡 Got a new trial idea to improve outcomes for men with prostate cancer? 🗓 Deadline: 4pm, Fri 13 Feb ⤵️Use our form & submit your proposal below.

🎉 BREAKING NEWS Abiraterone is now approved for NHS use in England for men with high-risk localised or locally advanced prostate cancer, bringing England in line with Wales & Scotland. Stay tuned — we’ll share more on what this means for you and your patients next week. Read more: buff.ly/jRDKPrv

Could targeted alpha therapy be an effective treatment for advanced #ProstateCancer? An international team, including Prostate Cancer UK-funded researcher Dr Victoria Dunne @qubelfastofficial.bsky.social, publish new findings in Scientific Reports. Grab a ☕ & read: doi.org/10.1038/s415...

Take on our step challenge, March the Month, this March. Walk 11,000 steps a day throughout March for the over 11,000 men who die of #ProstateCancer every year. Sign up now 👉 bit.ly/44HPo01

The UK NSC is currently running a public consultation on its draft recommendation for prostate cancer screening. We are encouraging you to review the proposal and submit your views to help shape the final recommendation. More details here ➡️

⏰Reminder: CRSG proposal deadline approaching 💡Got a new trial idea to improve outcomes for men with prostate cancer? Use our form & submit your proposal. Deadline: 4pm, Fri 13 Feb 🔗https://buff.ly/W0foIBz

How has #ProstateCancer treatment evolved over the last five years? Prostate Cancer UK Scientific Advisory Board member Dr Jochen Walz @paoli-calmettes.bsky.social and @alison-tree.bsky.social review prostate cancer treatment progress in @thelancet.com. Grab a ☕ and read: doi.org/10.1016/S014...

🗓️One week today! 🙌Join Prof Emma Hall & Claire Snowdon from the @icr-ctsu.bsky.social to learn how Clinical Trials Units can elevate your research, or your career! ⤵️Register below

Thank you Adam - we're very grateful for your support this month, and for all you do year round to drive progress for men through research - always going the extra mile 🏃‍♂️🙏

🌟 Ready to lead the change in transforming prostate cancer care? 🚀 Gain crucial leadership and change management skills on our Clinical Champions Programme! 🌐✨ Apply now

In light of the growing body of evidence around screening the APPG on #ProstateCancer we were delighted to hear from experts from within the European Praise-U consortium earlier this year about the approaches and methods being undertaken in other countries. Read the report here: buff.ly/uqqAMNU

The December edition of Research News is here! Find out about: 🔬 An exciting research project. 💻 A new webinar series. 🩺 UK Prostate Cancer Clinical Research Strategy Group. 💬 Discussion session topic at From Ideas to Innovation. 📚 Read it here: buff.ly/kXTXjdx

Excited to share our new study from @asharpmedonc.bsky.social lab at @icr.ac.uk 🔬✨ We identify therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer. So happy to have to co-led this work with my colleagues and friends #DanWestaby & @inesfigueiredo.bsky.social 🔗 bit.ly/4oHSvNx

Could targeting MCL1 & BCLXL be effective in advanced #ProstateCancer? Research in @cp-iscience.bsky.social led by Dr Westaby, @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social & Prof de Bono, supported by our Movember London Centre of Excellence. Grab a ☕ & read: doi.org/10.1016/j.is...

Upcoming webinar: Augmented SBRT & precision in prostate cancer treatment. Hear about current approaches, practical considerations developments within this area. 📅 Jan 28 ⏰ 3:00–4:30 CEST 📍 Zoom Register: bit.ly/492iMjT

Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience. 🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.

🖥️ Don't miss the next webinar from the European Prostate Cancer Alliance on 'Tumour heterogeneity and molecular imaging', featuring Prostate Cancer UK funded researchers Professor Hing Leung and Professor Craig Robson. 📆 15th December ⏰ 15:00 - 17:15 🔗 t.co/ejVkwgiij9

Dr Joaquin Mateo was a research fellow @icr.ac.uk interested in making personalised #ProstateCancer treatments. In 2014, we funded him to see if men with specific DNA mutations responded favourably to a drug called olaparib. 📙 Read more: prostatecanceruk.org/research/res...

Could machine learning be a future tool to predict protein-protein interactions in #ProstateCancer? A team including Prostate Cancer UK funded Dr Ke Yuan @uofgcancersciences.bsky.social take protein language models a step forward in @natcomms.nature.com. Grab a ☕ and read: doi.org/10.1038/s414...

If you’re a Black healthcare professional, we want to help you drive change in prostate cancer care. Our Clinical Champions Programme will support you to become a transformative leader and make a lasting impact. Apply now 👉

🗣️ YOUR FEEDBACK MATTERS Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations. Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH

Screening takes time but early diagnosis can’t wait. Keep supporting men at risk and stay informed with our latest guidance, education and clinical resources. Sign up to our health professional e-newsletter ➡️ bit.ly/2VktI7b

Ready to lead impactful change? Apply now to be a part of our award-winning 18-month flagship programme. 🌟Apply now: bit.ly/46I5Fn9

📣 We’re looking forward to the discussion session at From Ideas to Innovation, which will explore Equity in Research Career Progression. 🙏We’re grateful to our research community for sharing their insights and experiences. ⬇️ Check out the full agenda. prostatecanceruk.org/research/for...

🥼 Meet Prof Hashim Ahmed and Prof Mark Emberton, researchers and clinicians dedicated to improving the way we diagnose men with prostate cancer. Find out more ➡️ bit.ly/3xSHfYS

🥼 Meet Dr Bunmi Olajide, a GP dedicated to improving cancer care and raising awareness of Black men’s higher risk of prostate cancer. Learn more ➡️ bit.ly/4ip3ysp

🗣️ YOUR FEEDBACK MATTERS Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations. Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH

Could dose–response model parameters influence identification of bladder regions vulnerable to radiotherapy-induced toxicity? A team led by Dr Tanuj Puri, Prof Marcel van Herk & Dr Alan McWilliam @manchester.ac.uk share new findings in Physica Medica. Grab a ☕ & read: doi.org/10.1016/j.ej...

While the NSC has recommended screening only for men with BRCA gene variations, this isn’t the end of the story. Our ongoing research, including TRANSFORM, will provide the evidence needed to expand screening safely in the future. Find out more ➡️ bit.ly/3xSHfYS